Jason Throne, SVP, General Counsel at IDEAYA Biosciences, Inc. (IDYA), sold 1,979 shares at $15.55 ($30K) on 2020-12-04, disclosed to the SEC on 2020-12-08.
Scheduled sale ($30k) by SVP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.66 | 400 | $6K | 19.3% |
| 2 | $15.55 | 1,579 | $25K | 80.7% |
| Total | $15.37 avg | 1,979 | $30K | 100% |
| Filing → |
| IDYA | SELL | 2023-09-14 | $30K | — | Filing → |
| IDYA | SELL | 2023-09-06 | $167K | — | Filing → |
| IDYA | SELL | 2023-08-11 | $125K | — | Filing → |